Is Recombinant Bovine Growth Hormone banned?
Yes. Recombinant Bovine Growth Hormone is banned, restricted, or carries a mandatory warning label in 5 countries including European Union, Canada, Japan. The US FDA still permits it, which is why it shows up in everyday American food and beauty products.
Countries where Recombinant Bovine Growth Hormone is banned or restricted
| Country / Region | Status |
|---|---|
| European Union | Banned or restricted |
| Canada | Banned or restricted |
| Japan | Banned or restricted |
| Australia | Banned or restricted |
| New Zealand | Banned or restricted |
Why Recombinant Bovine Growth Hormone is flagged
The central human health concern is that rBGH treatment significantly elevates insulin-like growth factor 1 (IGF-1) levels in treated cows' milk. IGF-1 is a naturally occurring growth hormone that promotes cell growth and division. Multiple epidemiological studies have associated elevated blood IGF-1 levels with increased cancer risk in humans. A 1998 study in The Lancet (Hankinson et al.) found that women with the highest IGF-1 blood levels had approximately 7 times the breast cancer risk compared to those with the lowest levels. A 2004 meta-analysis in JNCI (the Journal of the National Cancer Institute) confirmed significant associations between high IGF-1 levels and breast, prostate, and colorectal cancer risk. The mechanistic question is whether consuming rBGH-treated milk raises blood IGF-1 levels in humans. The FDA and WHO/FAO Codex Alimentarius concluded that IGF-1 in milk is a protein largely digested in the GI tract before absorption. Canadian regulatory researchers challenged this, arguing that pasteurization reduces proteases that would otherwise break down IGF-1, potentially allowing more intact IGF-1 to survive digestion. The Codex Alimentarius Commission made history in 1999 by declining to endorse rBST safety maximum residue limits — a split vote (33 in favor of the MRL, 29 against, with abstentions) demonstrating fundamental international disagreement. This is one of very few cases where Codex failed to establish a safety standard. Animal welfare is a second major concern: Health Canada's comprehensive 1999 review found that rBGH-treated cows had 25% higher rates of clinical mastitis, 50% higher lameness risk, increased reproductive problems, and shortened productive lifespans, requiring substantially more antibiotic treatment — an antibiotic resistance concern. Canada rejected rBGH approval in 1999 after its scientific review; the EU banned it in 1999.
Scan your pantry for Recombinant Bovine Growth Hormone
Get a free Safe / Caution / Avoid score on any US food or beauty barcode \u2014 with EFSA + FDA citations.
Scan a product \u2192See the full Recombinant Bovine Growth Hormone deep-dive page for regulatory citations, products that contain it, and verified clean swaps.